Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.025
Bid: 1.00
Ask: 1.05
Change: -0.108 (-9.53%)
Spread: 0.05 (5.00%)
Open: 1.075
High: 1.075
Low: 1.025
Prev. Close: 1.133
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Annual Report and Notice of AGM

20 May 2021 07:00

RNS Number : 2130Z
Microsaic Systems plc
20 May 2021
 

20 May 2021

Microsaic Systems plc

("Microsaic" or the "Company")

Posting of Annual Report, Notice of Annual General Meeting

and

Electronic Communications

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that its 2020 Annual Report and Notice of 2021 Annual General Meeting ("Notice of AGM"), are available for viewing on the Company's website at https://www.microsaic.com/investors/documents/. These items will be posted to shareholders today, together with the Form of Proxy for voting at the Annual General Meeting ("AGM"), a copy of the Articles of Association the Company proposes to adopt, in a clean and comparison format showing the composite changes to the current Articles of Association (as detailed below) and a letter regarding its intention to adopt electronic communication methods for shareholder documents.

 

The Company will hold its AGM at GMS House, Boundary Road, Woking, Surrey, GU21 5BX on 17 June 2021 at 10.00 a.m.

 

Under normal circumstances, the Board values greatly the opportunity to meet shareholders in person. However, the Board considers the safety and wellbeing of both its shareholders and employees to be of paramount importance. With this in mind, and in light of the COVID-19 pandemic, the Chairman of the meeting and one other person will attend the AGM thus fulfilling the requirement of the Company's Articles of Association for a quorum to be present consisting of two persons entitled to vote upon the business to be transacted, present in person or by proxy. Accordingly, on health and safety grounds other shareholders and proxies for shareholders will not be permitted to attend the AGM and shareholders are urged to submit the Form of Proxy instead. Details for completing and submitting the Form of Proxy are contained in the Notice of AGM, the accompanying notes and on the Form of Proxy itself.

 

The Board always welcomes questions from shareholders at the AGM. This year, shareholders should submit their questions directly to the Company before 10.00 a.m. on 15 June 2021 by emailing them to info@microsaic.com. The Company will publish relevant questions received, together with answers, on the Company's website as soon as practicable after the deadline for receipt. The questions may be grouped into generic classes as the Directors deem appropriate and answers will not include any inside information as defined by the Market Abuse Regulation.

 

There will also be the opportunity to raise questions with key members of the Board in a live Q&A session to be held immediately after the AGM. Details of how to join the Q&A session will be published in a RNS at least 72 hours before the date and time of the AGM. Answers will not include any inside information as defined by the Market Abuse Regulation.

 

Details of the resolutions to be proposed at the AGM are set out in the Notice of AGM, which also includes explanatory notes for each resolution. The resolutions are normal routine items, except for resolutions 6 and 7, both special resolutions. Resolution 6 seeks the annual renewal of the authority for the Directors to allot securities for cash which may be issued to raise funds for general corporate purposes without first offering such new shares to existing shareholders. Resolution 7 relates to the adoption of new Articles of Association so that the Company can hold hybrid or virtual general and annual general meetings in the future.

 

The results of voting on the resolutions at the AGM will be announced shortly after the meeting and will subsequently be made available on the Company's website.

 

The Board will continue to monitor COVID-19 developments as well as any further UK Government advice and will issue a further statement if the above arrangements require any amendment.

 

Electronic Communications

 

Microsaic has written to all registered shareholders regarding its intention to adopt electronic communication methods for certain shareholder documents.

 

The Board believes that by utilising electronic communication it will deliver savings to the Company in terms of administration, printing and postage, and environmental benefits through the reduced consumption of paper and ink, as well as speeding up the provision of information to shareholders.

 

A letter setting out the options available to shareholders, is being sent to shareholders on the register as at 14 May 2021. Shareholders wishing to continue to receive shareholder documents in hard copy form will need to notify the Company's registrar, Neville Registrars Limited, by no later than 16 June 2021, by completing and returning the Preferred Option Card using the reply paid envelope provided.

 

Shareholders who do not return the response form by the designated date will be deemed to have consented to receiving shareholder documents by means of Microsaic's website at www.microsaic.com and will no longer receive documents in hard copy form.

 

Further details are set out in the letter, which will shortly be available on the Company's website.

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO - Bevan Metcalf, FD

+44 (0)1483 751 577

N+1 Singer (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking) 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / Zoe Alexander

+44 (0) 20 3657 0050

 

About Microsaic (www.microsaic.com)

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

Microsaic's products and systems are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAESNFELFEAA
Date   Source Headline
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting
4th Jun 20217:00 amRNSPre-Annual General Meeting Q&A
25th May 20217:00 amRNSDevelopment of PFAS detection platform
20th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:01 amRNSHeads of Terms signed for Chinese market
4th May 20217:00 amRNSFinal Results
28th Apr 20217:00 amRNSNotice of Results and Investor Presentation
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFramework Services Agreement Update
9th Mar 20212:52 pmRNSHolding(s) in Company
9th Mar 20212:06 pmRNSSecond Price Monitoring Extn
9th Mar 20212:01 pmRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.